Position in GOSS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$65,459
-$978,696 QoQ
Shares Held
396,727
-87.5% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 168 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Derivatives in GOSS
reported options exposure · as of Sep 30, 2021CallValue
$320,535
CallShares
25,500
PutValue
$320,535
PutShares
25,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. GOSS ranks #320 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in GOSS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,459 | 396,727 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,044,155 | 3,173,725 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,910,671 | 1,906,669 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,579,405 | 2,881,904 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $82,506 | 67,080 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $180,212 | 163,830 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $76,732 | 84,788 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,347 | 40,922 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $38,098 | 42,287 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $141,558 | 119,966 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $74,595 | 81,705 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $80,438 | 96,566 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $124,657 | 103,881 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $288,450 | 228,930 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,603,974 | 3,043,307 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $4,282,596 | 357,479 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,790,118 | 452,822 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,586,352 | 297,967 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,868,835 | 253,655 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $320,535 | 25,500 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $320,535 | 25,500 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $1,174,979 | 93,475 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $596,575 | 73,470 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,327,014 | 143,461 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $718,721 | 74,325 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $906,908 | 73,079 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $515,853 | 39,681 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $382,511 | 37,686 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||